chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Rash, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: swollen eye; sore arm; not a common rash, it was the same type of rash observe in Covid-19 patients; This spontaneous case was reported by a health care professional and describes the occurrence of EYE SWELLING (swollen eye), VACCINATION SITE PAIN (sore arm) and RASH (not a common rash, it was the same type of rash observe in Covid-19 patients) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 24-Jan-2021, the patient experienced EYE SWELLING (swollen eye), VACCINATION SITE PAIN (sore arm) and RASH (not a common rash, it was the same type of rash observe in Covid-19 patients). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE SWELLING (swollen eye), VACCINATION SITE PAIN (sore arm) and RASH (not a common rash, it was the same type of rash observe in Covid-19 patients) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient treatment includes steroids and Benadryl. Concomitant medication was not provided.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: painful to raise her arm; pain at site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (painful to raise her arm) and INJECTION SITE PAIN (pain at site of the injection) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation. Concomitant products included ATORVASTATIN, METOPROLOL, DILTIAZEM HYDROCHLORIDE (CARDIZEM CD), BRIMONIDINE TARTRATE (ALPHAGAN), BIMATOPROST (LUMIGAN), NETARSUDIL MESILATE (RHOPRESSA), DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMIDE HCL + TIMOLOL MALEATE) and DABIGATRAN ETEXILATE MESILATE (PRADAXA) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (painful to raise her arm) and INJECTION SITE PAIN (pain at site of the injection). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 500 mg three times a day. On 04-Feb-2021, PAIN IN EXTREMITY (painful to raise her arm) and INJECTION SITE PAIN (pain at site of the injection) had resolved.            Action taken with mRNA-1273 in response to the drug was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received. Added the Fax number of the reporter.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Nausea, Pain, Temperature difference of extremities
Clinical narrative: having trouble breathing; temperature; nausea; lots of pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (having trouble breathing), PAIN (lots of pain), TEMPERATURE DIFFERENCE OF EXTREMITIES (temperature) and NAUSEA (nausea) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (lots of pain). On 04-Feb-2021, the patient experienced DYSPNOEA (having trouble breathing), TEMPERATURE DIFFERENCE OF EXTREMITIES (temperature) and NAUSEA (nausea). At the time of the report, DYSPNOEA (having trouble breathing), PAIN (lots of pain), TEMPERATURE DIFFERENCE OF EXTREMITIES (temperature) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Had a sore shoulder for a few days; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ARTHRALGIA (shoulder soreness). At the time of the report, ARTHRALGIA (shoulder soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to the touch; Itchy IS; Huge red spot in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchy IS) and VACCINATION SITE ERYTHEMA (Huge red spot in the arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchy IS) and VACCINATION SITE ERYTHEMA (Huge red spot in the arm). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchy IS) and VACCINATION SITE ERYTHEMA (Huge red spot in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. concomitant medication was not provided
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Weird red spot 2-3 inches in diameter below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Weird red spot 2-3 inches in diameter below the injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Weird red spot 2-3 inches in diameter below the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Weird red spot 2-3 inches in diameter below the injection site) outcome was unknown.            No concomitant and treatment medication were reported.  Action taken with mRNA-1273 in response to the event was not applicable
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Pyrexia, Somnolence
Clinical narrative: sleeping a lot; feeling very tired; Very cold, freezing; chills; feverish with temperature of 100 F; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (sleeping a lot), FATIGUE (feeling very tired), FEELING COLD (Very cold, freezing), CHILLS (chills) and PYREXIA (feverish with temperature of 100 F) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included GLICLAZIDE (MICROZIDE [GLICLAZIDE]), METFORMIN, ATENOLOL (TENORMIN), ATORVASTATIN CALCIUM (LIPITOR), AMLODIPINE (NORVASK [AMLODIPINE]) and WARFARIN for an unknown indication, VITAMINS NOS.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeping a lot), FATIGUE (feeling very tired), FEELING COLD (Very cold, freezing), CHILLS (chills) and PYREXIA (feverish with temperature of 100 F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (sleeping a lot), FATIGUE (feeling very tired), FEELING COLD (Very cold, freezing), CHILLS (chills) and PYREXIA (feverish with temperature of 100 F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 100 f 100 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMIN C [ASCORBIC ACID], TOCOPHEROL (VITAMIN E [TOCOPHEROL]), TURMERIC [CURCUMA LONGA RHIZOME], ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), MULTI VITAMIN & MINERAL, ATORVASTATIN, LISINOPRIL and METOPROLOL for an unknown indication.    On 23-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ARTHRALGIA (Sore shoulder). At the time of the report, ARTHRALGIA (Sore shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Tenderness, Vaccination site erythema, Vaccination site pain
Clinical narrative: Red patch and it was itchy; Tender to touch injection site; Pain in my arm, sore - (left arm) vaccination site.; Redness - (left arm) vaccination site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in my arm, sore - (left arm) vaccination site.), VACCINATION SITE ERYTHEMA (Redness - (left arm) vaccination site.), RASH PRURITIC (Red patch and it was itchy) and TENDERNESS (Tender to touch injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain in my arm, sore - (left arm) vaccination site.), VACCINATION SITE ERYTHEMA (Redness - (left arm) vaccination site.) and TENDERNESS (Tender to touch injection site). On an unknown date, the patient experienced RASH PRURITIC (Red patch and it was itchy). At the time of the report, VACCINATION SITE PAIN (Pain in my arm, sore - (left arm) vaccination site.), VACCINATION SITE ERYTHEMA (Redness - (left arm) vaccination site.), RASH PRURITIC (Red patch and it was itchy) and TENDERNESS (Tender to touch injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. concomitant medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: soreness in my arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness in my arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness in my arm). At the time of the report, MYALGIA (soreness in my arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       Treatment information was not provided. Concomitant information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Adverse Event NOS; A spontaneous report was received from a consumer concerning a female patient of unknown age received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events possible side effect.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) possible side effect.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), possible side effect was unknown.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Heart was racing; fever of 101.4; nausea; Body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Heart was racing), PYREXIA (fever of 101.4), NAUSEA (nausea), MYALGIA (Body aches) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010MZ0A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020. Concomitant products included ANASTROZOLE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced TACHYCARDIA (Heart was racing), PYREXIA (fever of 101.4), NAUSEA (nausea), MYALGIA (Body aches) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Heart was racing), PYREXIA (fever of 101.4), NAUSEA (nausea), MYALGIA (Body aches) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 101.4 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Heart was racing; fever of 101.4; nausea; Body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Heart was racing), PYREXIA (fever of 101.4), NAUSEA (nausea), MYALGIA (Body aches) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010MZ0A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020. Concomitant products included ANASTROZOLE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced TACHYCARDIA (Heart was racing), PYREXIA (fever of 101.4), NAUSEA (nausea), MYALGIA (Body aches) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Heart was racing), PYREXIA (fever of 101.4), NAUSEA (nausea), MYALGIA (Body aches) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 101.4 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site).   At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness at the site at the injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the site at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the site at the injection site).   At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the site at the injection site) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: VERY dizzy/faint and it's getting worse; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (VERY dizzy/faint and it's getting worse) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (VERY dizzy/faint and it's getting worse). At the time of the report, DIZZINESS (VERY dizzy/faint and it's getting worse) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient reported that the event they experienced was too bad to drive. No relevant concomitant medications were reported.  Treatment information was not provided.  Company comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: No new information was provided.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Poor quality sleep, Vaccination site pain
Clinical narrative: poor sleep; fatigue; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), FATIGUE (fatigue) and POOR QUALITY SLEEP (poor sleep) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M201A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). On 03-Feb-2021, the patient experienced FATIGUE (fatigue).   On 04-Feb-2021, the patient experienced POOR QUALITY SLEEP (poor sleep). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of UNK UNK, bid. On 03-Feb-2021, FATIGUE (fatigue) had resolved.   At the time of the report, VACCINATION SITE PAIN (pain at injection site) and POOR QUALITY SLEEP (poor sleep) had not resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Heart rate increased, Hypoaesthesia, Pain in extremity
Clinical narrative: Heart started to beat really fast; Tightness in his chest; Numbness; Pain like a pulled muscle under his left arm; I was a little tired than normal; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart started to beat really fast), CHEST DISCOMFORT (Tightness in his chest), HYPOAESTHESIA (Numbness), PAIN IN EXTREMITY (Pain like a pulled muscle under his left arm) and FATIGUE (I was a little tired than normal) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HEART RATE INCREASED (Heart started to beat really fast), CHEST DISCOMFORT (Tightness in his chest), HYPOAESTHESIA (Numbness), PAIN IN EXTREMITY (Pain like a pulled muscle under his left arm) and FATIGUE (I was a little tired than normal). On 22-Jan-2021, HYPOAESTHESIA (Numbness) and FATIGUE (I was a little tired than normal) had resolved. At the time of the report, HEART RATE INCREASED (Heart started to beat really fast) and PAIN IN EXTREMITY (Pain like a pulled muscle under his left arm) outcome was unknown and CHEST DISCOMFORT (Tightness in his chest) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded   Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: Additional information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rashes on the upper abdomen. chest and wide spread at the back.; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH (Rashes on the upper abdomen. chest and wide spread at the back.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Methimazole                                                    for Grave's Dse for Graves' disease, Atenolol                                                       for hypertension for Hypertension.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced RASH (Rashes on the upper abdomen. chest and wide spread at the back.). At the time of the report, RASH (Rashes on the upper abdomen. chest and wide spread at the back.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Neurological symptom, Pharyngeal swelling, Tremor
Clinical narrative: severe tremor shakes; Neurological symptoms; throat & mouth began to swell; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL SWELLING (throat & mouth began to swell), TREMOR (severe tremor shakes) and NEUROLOGICAL SYMPTOM (Neurological symptoms) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 22-Jan-2021, the patient experienced PHARYNGEAL SWELLING (throat & mouth began to swell). On 28-Jan-2021, the patient experienced TREMOR (severe tremor shakes) and NEUROLOGICAL SYMPTOM (Neurological symptoms). The patient was treated with CLONAZEPAM for Tremor, at an unspecified dose and frequency; VALPROATE SEMISODIUM (DEPAKOTE) at an unspecified dose and frequency; VITAMIN C [ASCORBIC ACID] at an unspecified dose and frequency; ZINC at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency; VITAMIN D NOS at an unspecified dose and frequency; CALCIUM at an unspecified dose and frequency; OMEGA-3 NOS at an unspecified dose and frequency; MAGNESIUM at an unspecified dose and frequency and VITAMIN E NOS at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (throat & mouth began to swell), TREMOR (severe tremor shakes) and NEUROLOGICAL SYMPTOM (Neurological symptoms) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Feeling hot, Headache, Influenza like illness
Clinical narrative: Flu-like; Hot; Sore arm; Low level fever of 100.3 degrees; Muscle ache; Joint aches; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like), FEELING HOT (Hot), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low level fever of 100.3 degrees) and MYALGIA (Muscle ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event history).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like), FEELING HOT (Hot), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low level fever of 100.3 degrees), MYALGIA (Muscle ache), ARTHRALGIA (Joint aches), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like), FEELING HOT (Hot), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low level fever of 100.3 degrees), MYALGIA (Muscle ache), ARTHRALGIA (Joint aches), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.            Treatment information was not provided. Concomitant medication was not provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Flu-like; Hot; Sore arm; Low level fever of 100.3 degrees; Muscle ache; Joint aches; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like), FEELING HOT (Hot), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low level fever of 100.3 degrees) and MYALGIA (Muscle ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event history).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like), FEELING HOT (Hot), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low level fever of 100.3 degrees), MYALGIA (Muscle ache), ARTHRALGIA (Joint aches), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like), FEELING HOT (Hot), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low level fever of 100.3 degrees), MYALGIA (Muscle ache), ARTHRALGIA (Joint aches), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.            Treatment information was not provided. Concomitant medication was not provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Lymph node pain, Lymphadenopathy, Pain, Pain in extremity
Clinical narrative: lymph nodes are swelling (colar bone area); lymph nodes are sore (colar bone area); sore in her collar bone area that brings pain; discomfort; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), LYMPHADENOPATHY (lymph nodes are swelling (colar bone area)), LYMPH NODE PAIN (lymph nodes are sore (colar bone area)), PAIN (sore in her collar bone area that brings pain) and DISCOMFORT (discomfort) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMIN B COMPLEX for B12, VITAMIN D [VITAMIN D NOS].    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 05-Feb-2021, the patient experienced LYMPHADENOPATHY (lymph nodes are swelling (colar bone area)), LYMPH NODE PAIN (lymph nodes are sore (colar bone area)), PAIN (sore in her collar bone area that brings pain) and DISCOMFORT (discomfort). The patient was treated with PHENIRAMINE MALEATE (AVIL [PHENIRAMINE MALEATE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness), LYMPHADENOPATHY (lymph nodes are swelling (colar bone area)), LYMPH NODE PAIN (lymph nodes are sore (colar bone area)), PAIN (sore in her collar bone area that brings pain) and DISCOMFORT (discomfort) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication Vitamin B complex , Vitamin D used for B12, bine health and skin.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Illness, Nausea
Clinical narrative: feel really sick; diarrhea; dizziness; nausea; chills; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (feel really sick), DIARRHOEA (diarrhea), DIZZINESS (dizziness), NAUSEA (nausea) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (feel really sick), DIARRHOEA (diarrhea), DIZZINESS (dizziness), NAUSEA (nausea) and CHILLS (chills). At the time of the report, ILLNESS (feel really sick), DIARRHOEA (diarrhea), DIZZINESS (dizziness), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concominant medication was not provided. Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurt). At the time of the report, PAIN IN EXTREMITY (arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Bumps at site of injection; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Bumps at site of injection) and VACCINATION SITE PAIN (Soreness of arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Bumps at site of injection) and VACCINATION SITE PAIN (Soreness of arm). At the time of the report, VACCINATION SITE SWELLING (Bumps at site of injection) and VACCINATION SITE PAIN (Soreness of arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant information was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Energy increased
Clinical narrative: Felt more energetic like never before; This spontaneous case was reported by a consumer and describes the occurrence of ENERGY INCREASED (Felt more energetic like never before) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ENERGY INCREASED (Felt more energetic like never before). At the time of the report, ENERGY INCREASED (Felt more energetic like never before) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Urine analysis abnormal
Clinical narrative: pain in arm; trouble urinating; fever 101F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), URINE ANALYSIS ABNORMAL (trouble urinating) and PYREXIA (fever 101F) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Heart disease, unspecified, FINASTERIDE for Prostate cancer, MULTIVITAMINS [VITAMINS NOS], FISH OIL, VITAMIN C [ASCORBIC ACID] and MAGNESIUM for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), URINE ANALYSIS ABNORMAL (trouble urinating) and PYREXIA (fever 101F). At the time of the report, PAIN IN EXTREMITY (pain in arm), URINE ANALYSIS ABNORMAL (trouble urinating) and PYREXIA (fever 101F) outcome was unknown. Not Provided
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Back pain, Chills, Fatigue, Pain in extremity
Clinical narrative: chills; fatigue; Arm soreness; lower back pain; loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), BACK PAIN (lower back pain), AGEUSIA (loss of taste), CHILLS (chills) and FATIGUE (fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Stent placement. Concomitant products included ISOSORBIDE for Heart disease, unspecified, METOPROLOL for Hypertension, ATORVASTATIN for an unknown indication.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), BACK PAIN (lower back pain) and AGEUSIA (loss of taste). On 07-Feb-2021, the patient experienced CHILLS (chills) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Feb-2021, AGEUSIA (loss of taste) had resolved. On 03-Feb-2021, PAIN IN EXTREMITY (Arm soreness) and BACK PAIN (lower back pain) had resolved. At the time of the report, CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included atorvastatin for cholesterol and multivitamins. Treatment information included water.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain in extremity
Clinical narrative: Body ache; Chills; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 05-Feb-2021, the patient experienced MYALGIA (Body ache) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache) and CHILLS (Chills) had not resolved.            Concomitant and treatment information not provided. No Treatment information was provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Non-significant follow up appended
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Chills; Nausea; Headache; Fever 101.4; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever 101.4) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever 101.4). The patient was treated with PARACETAMOL (TYLENOL) for Adverse drug reaction, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever 101.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 101.4 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Red and warm-to-the-touch arm; Red and warm-to-the-touch arm; Migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), VACCINATION SITE WARMTH (Red and warm-to-the-touch arm) and VACCINATION SITE ERYTHEMA (Red and warm-to-the-touch arm) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included RIVAROXABAN (XARELTO) and STEROIDS for an unknown indication.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced MIGRAINE (Migraine). On 23-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Red and warm-to-the-touch arm) and VACCINATION SITE ERYTHEMA (Red and warm-to-the-touch arm). In February 2021, MIGRAINE (Migraine) had resolved. At the time of the report, VACCINATION SITE WARMTH (Red and warm-to-the-touch arm) and VACCINATION SITE ERYTHEMA (Red and warm-to-the-touch arm) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product also included supplements.  Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Influenza like illness, Musculoskeletal discomfort
Clinical narrative: diarrhea; feel a little shaky and a little off; feel like post flu; very bad body aches; lots of sputum; nausea; vomiting; terrible headache; chills; really hit me hard; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (diarrhea), NERVOUSNESS (feel a little shaky and a little off), INFLUENZA LIKE ILLNESS (feel like post flu), PAIN (very bad body aches) and PRODUCTIVE COUGH (lots of sputum) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIARRHOEA (diarrhea), NERVOUSNESS (feel a little shaky and a little off), INFLUENZA LIKE ILLNESS (feel like post flu), PAIN (very bad body aches), PRODUCTIVE COUGH (lots of sputum), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (terrible headache), CHILLS (chills) and MUSCULOSKELETAL DISCOMFORT (really hit me hard). At the time of the report, DIARRHOEA (diarrhea), NERVOUSNESS (feel a little shaky and a little off), INFLUENZA LIKE ILLNESS (feel like post flu), PAIN (very bad body aches), PRODUCTIVE COUGH (lots of sputum), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (terrible headache), CHILLS (chills) and MUSCULOSKELETAL DISCOMFORT (really hit me hard) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.